Written and medically reviewed by Dr. Diane Mueller, ND, LAc, DAOM, founder of MyLymeDoc. Last reviewed September 1, 2026.
Yes, early Lyme disease can be cured. Treated promptly with standard antibiotics, more than 80% of people have complete resolution of symptoms at long-term follow-up, and one large study found 99% remained treatment-failure free at two years. That is a genuinely good outcome and it deserves to be stated without hedging. The harder question is the one most people arrive with: what happens if you were treated and still feel unwell. That answer is less satisfying, and this page gives it straight, including the evidence that does not favor how clinics like ours are often expected to answer.
For early Lyme disease caught and treated in the first weeks, the answer is yes.
A clinical review reports that for early localized disease treated with standard antibiotics, “greater than 80% of patients will have complete resolution of symptoms at long-term follow-up,” with similar results across amoxicillin, cefuroxime, azithromycin and doxycycline. A large retrospective study found “99% of patients with early local or disseminated Lyme remaining treatment-failure free at two years,” regardless of whether treatment ran 10 days, 11 to 15 days, or longer.
That is the part of the picture that gets lost in the argument about chronic Lyme. Early treatment works, and works well. Understanding how fast Lyme disease progresses is what gets people into that window.
| Stage | What the evidence shows |
|---|---|
| Early localized | Greater than 80% complete resolution at long-term follow-up |
| Early local or disseminated | 99% treatment-failure free at two years in a large retrospective study |
| Late Lyme arthritis | Below 50% in some placebo-controlled work; a European trial found 87.9% remission with ceftriaxone and 61.3% with penicillin |
| Persistent symptoms after treatment | No reliable cure rate exists, because the cause is disputed |
The pattern is consistent. The earlier it is treated, the better the outcome. That is why the tick-bite window matters so much, though prophylaxis after a bite is not automatic either: a 2021 meta-analysis found single-dose doxycycline reduced Lyme risk substantially, but calculated that about 50 people would need treating to prevent one case, and concluded routine prophylaxis is not recommended without high-risk features such as prolonged attachment.
Here the evidence genuinely splits, and this page is not going to pretend otherwise.
The mainstream position is that persistent symptoms after treatment occur at roughly the rate you would see anyway. The review cited above states that while patients “may have symptoms that persist or appear after treatment is complete, the frequency of those symptoms is comparable with what one would see in individuals who do not have Lyme disease.” A Slovenian study found only 2.2% reported new or increased symptoms at 12 months, none disabling.
The other position is that a real population remains genuinely unwell after adequate treatment, and that dismissing them as background noise fails them. Proposed explanations include immune activation persisting after the organism is cleared, tissue damage from the original infection, untreated co-infections, and persistent infection itself.
We work with the second group. That is what this practice does. It would be dishonest not to also tell you that the first position is held by most of mainstream infectious disease medicine, and that it is supported by real data.
That picture has a name, post-treatment Lyme disease syndrome, usually shortened to PTLDS, and it is a recognized clinical entity rather than a fringe one. More on it is at post-treatment Lyme disease syndrome.
Erythema migrans is the expanding rash of early Lyme disease, caused by Borrelia burgdorferi. Its presence allows treatment to start before any blood test comes back, which is the single biggest driver of a good outcome.
The specific diagnostic label used for symptoms that persist after adequate treatment is covered on post-treatment Lyme disease syndrome.
This is the part most sites in this space leave out, and it should not be left out.
Four NIH-sponsored trials tested whether re-treating people who had persistent symptoms with more antibiotics helped. The conclusion was that “retreatment provides little if any benefit and carries significant risk,” and that a meaningful clinical benefit from repeat parenteral antibiotic therapy “cannot be justified.”
The numbers behind that are worth seeing. In the Klempner trials, 36% of placebo patients met the improvement standard against 40% of those given antibiotics. A four-point gap is not a treatment effect. In the Fallon study, ceftriaxone and placebo produced identical 15% reductions in fatigue scores. And life-threatening complications ran at 1.6% in the Klempner trials and 7.3% in the Krupp trial. Those are two separate per-trial figures, not a range, and the risk sits largely in the long-term intravenous line rather than in the drug alone. Three placebo participants in one trial developed catheter sepsis.
The trials were not uniformly null, and a page claiming to give you both sides has to say so. In the Krupp trial, fatigue scores fell 22% on ceftriaxone against 9.1% on placebo. Critics of this literature also point out that enrollment was restricted to patients with functionally disabling symptoms, which is a narrow slice of everyone who stays unwell. The reviewers’ position is that the effects seen were too small or too short-lived to justify the risk. That is a judgment call about the balance, not a demonstration that nothing happened. What is not a judgment call is that more antibiotics is not a safe default.
How a Lyme-literate practice should actually reason through a case like this is set out on Lyme disease specialist.
That last figure is the one to sit with. Long intravenous antibiotics are not a low-risk thing to try because nothing else has worked.
We are telling you the retreatment trials failed, on a page belonging to a clinic that treats people with persistent symptoms. That deserves an explanation rather than a change of subject.
What those trials tested is not what we do. They tested months of repeat antibiotics, often intravenous, aimed at killing an organism that may or may not still be present. Dr. Mueller’s approach runs in a different order: build the body first, regulate the nervous system, detox gently, and only then do targeted microbe work. The evidence against prolonged antibiotic retreatment is not evidence against that, because it is not the same intervention.
What we do not claim. We do not claim chronic Lyme is a proven persistent infection. We do not claim to cure persistent symptoms. We do not offer the long antibiotic courses those trials tested.
What we do claim. Many people arrive having never had their full picture examined, including mold exposure, co-infections, nutrient depletion, thyroid and adrenal function, and nervous system dysregulation. Looking for what is actually driving symptoms is a different question from which antibiotic next. We do not publish an outcome rate for it, because we do not have one that would survive scrutiny, and a number we cannot defend is worth less to you than this sentence.
Early Lyme disease, yes. More than 80% of people treated promptly have complete resolution at long-term follow-up, and one large study found 99% treatment-failure free at two years.
You are not alone and you are not imagining it. What causes it is genuinely disputed, and no reliable cure rate exists for it. What is clear from four NIH trials is that more antibiotics is not the answer.
The evidence says no. Those trials found little or no benefit, with 36% of placebo patients meeting the improvement standard against 40% on antibiotics, and life-threatening complications at 1.6% in the Klempner trials and 7.3% in the Krupp trial, a risk carried by everyone on a long-term intravenous line.
People who remain unwell after treatment are real, and this practice works with them. Whether that is caused by ongoing infection is not established, and this page will not pretend the question is settled.
Do not count on it. Untreated infection can progress to joint, neurological and cardiac involvement, which is why the early treatment window matters so much.
No, and neither can anyone else. What can be offered is a thorough look at what is driving your symptoms and an honest assessment of what is likely to help.
Every source below was checked against the specific claim it supports.
Written and medically reviewed by Dr. Diane Mueller, ND, LAc, DAOM. Dr. Mueller is a naturopathic doctor and licensed acupuncturist who has worked with more than 1,000 patients across the seven states where MyLymeDoc is licensed. Most arrive after treatment elsewhere has not resolved their symptoms. Read more about the team.
Last reviewed: September 1, 2026
If you were treated and still feel unwell, a full evaluation can look at what else may be driving it. You can book an initial visit.
MyLymeDoc is licensed in seven states only. If you live elsewhere, an infectious disease consult arranged through your own doctor is the right next step, and the NIH Lyme disease information page is a neutral place to start reading.
Whatever you decide, do not start or stop antibiotics based on a web page. That conversation belongs with the clinician who knows your history.
This page is for general educational purposes and is not medical advice. It does not create a doctor and patient relationship, and it is not a substitute for diagnosis or treatment from your own clinician. Always talk with a qualified healthcare provider before starting, stopping, or changing any treatment. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room.
We have helped thousands of people in Colorado, Oregon, Wyoming, New Jersey, Pennsylvania, Texas, and Wisconsin restore their health and quality of life by diagnosing and treating their Lyme Disease.
We have helped thousands of
people restore their health
and quality of life by diagnosing
and treating their Lyme Disease.
“Dr. Mueller’s approach to medicine is refreshing! There is only so much you can do with western medicine and in my life I was needing a new approach. By addressing the whole body, nutritional diet factors, environmental factors, blood work, and incorporating ideas I had not previously known, I was able to break through with my conditions. I am not only experiencing less pain in my life, but through the process of healing guided by Dr. Diane Mueller, I am now happy to say I have more consciousness surrounding how I eat, what to eat and when things are appropriate. Living by example Dr. Mueller has a vibrancy that makes you want to learn and know more about your body and overall health. I highly recommend her to anyone looking for new answers, a new approach to health, or in need of freedom from pain and limitations.”
-Storie S.
Kihei, HI
